{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:03:38Z","timestamp":1783407818812,"version":"3.54.6"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2019\/34\/E\/NZ1\/00467"],"award-info":[{"award-number":["2019\/34\/E\/NZ1\/00467"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2022\/45\/B\/NZ7\/04269"],"award-info":[{"award-number":["2022\/45\/B\/NZ7\/04269"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2022\/06\/X\/NZ1\/01418"],"award-info":[{"award-number":["2022\/06\/X\/NZ1\/01418"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"National Agency for Academic Exchange","doi-asserted-by":"publisher","award":["PPN\/PPO\/2018\/1\/00046\/U\/00001"],"award-info":[{"award-number":["PPN\/PPO\/2018\/1\/00046\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.148124","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:21:05Z","timestamp":1759764065000},"page":"148124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P3","title":["Structural perspective on the design of selective DYRK1B inhibitors"],"prefix":"10.1016","volume":"330","author":[{"given":"Przemyslaw","family":"Grygier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pustelny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Jemiola-Rzeminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Suder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Czarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148124_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/0008-5472.CAN-17-2291","article-title":"New perspectives, opportunities, and challenges in exploring the human protein kinome","volume":"78","author":"Wilson","year":"2018","journal-title":"Cancer Res."},{"issue":"2002","key":"10.1016\/j.ijbiomac.2025.148124_bb0010","first-page":"1912","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1096\/fj.10-165837","article-title":"DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles","volume":"25","author":"Aranda","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0025","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1074\/jbc.271.7.3488","article-title":"Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII","volume":"271","author":"Kentrup","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60503-6","article-title":"Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity","volume":"62","author":"Becker","year":"1998","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169355","article-title":"The Omnipresence of DYRK1A in Human Diseases","volume":"23","author":"Deboever","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","article-title":"The role of DYRK1A in neurodegenerative diseases","volume":"278","author":"Wegiel","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114062","article-title":"DYRK1A inhibitors for disease therapy: current status and perspectives","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2015.03.004","article-title":"DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications","volume":"151","author":"Abbassi","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0055","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1242\/jcs.00618","article-title":"DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly","volume":"116","author":"\u00c1lvarez","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0060","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1078-0432.CCR-12-3433","article-title":"Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer","volume":"19","author":"Davis","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/gcc.20767","article-title":"19q13 amplification is associated with high grade and stage in pancreatic cancer","volume":"49","author":"Kuuselo","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/febs.14347","article-title":"A wake-up call to quiescent cancer cells \u2013 potential use of DYRK1B inhibitors in cancer therapy","volume":"285","author":"Becker","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0075","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cancers2031492","article-title":"The Kinase Mirk\/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer","volume":"2","author":"Friedman","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ijc.25692","article-title":"Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk\/dyrk1b and p130\/Rb2","volume":"129","author":"Hu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0085","first-page":"1203","article-title":"The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk\/Dyrk1B in ovarian cancer","volume":"40","author":"Gao","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0090","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.3390\/ijms14035560","article-title":"Mirk\/dyrk1B Kinase in Ovarian Cancer","volume":"14","author":"Friedman","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0095","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4161\/cbt.8.17.9322","article-title":"Mirk\/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells","volume":"8","author":"Gao","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2017.02.033","article-title":"Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis","volume":"66","author":"Chen","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0105","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-05-3089","article-title":"The kinase Mirk\/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma","volume":"66","author":"Deng","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0110","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1158\/0008-5472.CAN-05-1539","article-title":"Mirk\/Dyrk1b mediates cell survival in rhabdomyosarcomas","volume":"66","author":"Mercer","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18632\/genesandcancer.1","article-title":"The normal function of the cancer kinase Mirk\/dyrk1B is to reduce reactive oxygen species","volume":"5","author":"Deng","year":"2014","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0120","doi-asserted-by":"crossref","first-page":"13154","DOI":"10.18632\/oncotarget.22743","article-title":"Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0125","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/ijc.27917","article-title":"Ovarian cancer cells, not normal cells, are damaged by Mirk\/Dyrk1B kinase inhibition","volume":"132","author":"Hu","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092263","article-title":"DYRK1A kinase inhibitors promote \u03b2-cell survival and insulin homeostasis","volume":"10","author":"Barzowska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0135","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/acs.jmedchem.0c02050","article-title":"DYRK1A inhibitors as potential therapeutics for \u03b2-cell regeneration for diabetes","volume":"64","author":"Kumar","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0140","article-title":"Human beta cell regenerative drug therapy for diabetes: past achievements and future challenges","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132594","article-title":"Pharmacologic and genetic approaches define human pancreatic \u03b2 cell mitogenic targets of DYRK1A inhibitors","volume":"5","author":"Ackeifi","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019264","article-title":"\u03b2-Carboline compounds, including Harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer\u2019s disease-related sites","volume":"6","author":"Frost","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148124_bb0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0160","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1021\/acs.jmedchem.2c02068","article-title":"Comparative efficacy and selectivity of pharmacological inhibitors of DYRK and CLK protein kinases","volume":"66","author":"Lindberg","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0968-0004(94)90022-1","article-title":"The glycine-rich sequence of protein kinases: a multifunctional element","volume":"19","author":"Bossemeyer","year":"1994","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0170","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1093\/emboj\/16.18.5572","article-title":"Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog","volume":"16","author":"Hubbard","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.chembiol.2013.06.001","article-title":"Ins and outs of kinase DFG motifs","volume":"20","author":"Treiber","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0180","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.str.2013.03.012","article-title":"Structures of down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition","volume":"21","author":"Soundararajan","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0185","first-page":"1","article-title":"DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain","author":"Abu Jhaisha","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","article-title":"PEST sequences and regulation by proteolysis","volume":"21","author":"Rechsteiner","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20130461","article-title":"A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3\u03b2 to phosphorylate cyclin D1 at Thr286, not Thr288","volume":"457","author":"Ashford","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3590497","article-title":"Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A","volume":"359","author":"Himpel","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0205","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","article-title":"Activation, regulation, and inhibition of DYRK1A","volume":"278","author":"Becker","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-06423-0","article-title":"Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B","volume":"12","author":"Papenfuss","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0215","doi-asserted-by":"crossref","first-page":"C720","DOI":"10.1152\/ajpcell.00299.2014","article-title":"Mir-9 enhances the transactivation of nuclear factor of activated T cells by targeting KPNB1 and DYRK1B","volume":"308","author":"Zeng","year":"2015","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0220","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1021\/acs.jmedchem.2c00988","article-title":"Novel efficient multistage Lead optimization pipeline experimentally validated for DYRK1B selective inhibitors","volume":"65","author":"Alexandrov","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0225","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1021\/acs.jmedchem.2c01887","article-title":"Silmitasertib (CX-4945), a clinically used CK2-kinase inhibitor with additional effects on GSK3\u03b2 and DYRK1A kinases: a structural perspective","volume":"66","author":"Grygier","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0230","article-title":"Chai-1: decoding the molecular interactions of life","author":"Discovery","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0235","first-page":"1","article-title":"Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A","author":"Ogawa","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0240","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cub.2012.06.074","article-title":"Homeodomain-interacting protein kinase regulates yorkie activity to promote tissue growth","volume":"22","author":"Chen","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0245","article-title":"Homeodomain-interacting protein kinase (Hipk) plays roles in nervous system and muscle structure and function","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0250","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10288","article-title":"An extensive program of periodic alternative splicing linked to cell cycle progression","volume":"5","author":"Dominguez","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0255","doi-asserted-by":"crossref","first-page":"24246","DOI":"10.1074\/jbc.M314298200","article-title":"Manipulation of alternative splicing by a newly developed inhibitor of Clks","volume":"279","author":"Muraki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153724","article-title":"Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice","volume":"132","author":"Bhat","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0265","doi-asserted-by":"crossref","first-page":"877.3-877","DOI":"10.1096\/fasebj.22.1_supplement.877.3","article-title":"The involvement of calpain in homocysteine-induced apoptosis in SH-SY5Y cells","volume":"22","author":"Jang","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007540","article-title":"DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase","volume":"4","author":"Noll","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1073\/pnas.44.2.98","article-title":"Application of a theory of enzyme specificity to protein synthesis","volume":"44","author":"Koshland","year":"1958","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0280","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1021\/acs.jmedchem.7b01847","article-title":"Novel scaffolds for dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) inhibitors","volume":"61","author":"Czarna","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1107\/S1744309112051858","article-title":"Optimization of protein buffer cocktails using Thermofluor","volume":"69","author":"Reinhard","year":"2013","journal-title":"Acta Crystallogr. Sect. F"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106724","article-title":"A PCR protocol to establish standards for routine mycoplasma testing that by design detects over ninety percent of all known mycoplasma species","volume":"26","author":"Siegl","year":"2023","journal-title":"IScience"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0300","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0305","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1107\/S2059798323003595","article-title":"The CCP4 suite: integrative software for macromolecular crystallography","volume":"79","author":"Agirre","year":"2023","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0310","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0315","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0320","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0325","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0330","series-title":"Grade2 version 1.3.0","author":"Smart","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0335","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1021\/acs.jcim.2c00757","article-title":"ULYSSES: an efficient and easy to use Semiempirical library for C++","volume":"62","author":"Menezes","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0340","article-title":"Can quantum chemistry improve the understanding of protein-ligand interactions? Implications for structure based drug Discovery","author":"Menezes","year":"2023","journal-title":"BioRxiv"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0345","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1021\/acs.jctc.8b01176","article-title":"GFN2-xTB - an accurate and broadly parametrized self-consistent tight-binding quantum chemical method with multipole electrostatics and density-dependent dispersion contributions","volume":"15","author":"Bannwarth","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0350","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1021\/acs.jctc.1c00471","article-title":"Robust and efficient implicit solvation model for fast semiempirical methods","volume":"17","author":"Ehlert","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0360","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1073\/pnas.0408037102","article-title":"Potential energy functions for atomic-level simulations of water and organic and biomolecular systems","volume":"102","author":"Jorgensen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0365","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/acs.jpcb.7b00272","article-title":"1.14\u2217CM1A-LBCC: localized Bond-charge corrected CM1A charges for condensed-phase simulations","volume":"121","author":"Dodda","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0370","doi-asserted-by":"crossref","first-page":"W331","DOI":"10.1093\/nar\/gkx312","article-title":"LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands","volume":"45","author":"Dodda","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0375","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0380","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0385","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0390","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.33011\/livecoms.1.1.5068","article-title":"From proteins to perturbed Hamiltonians: a suite of tutorials for the GROMACS-2018 molecular simulation package [article v1.0]","volume":"1","author":"Lemkul","year":"2019","journal-title":"Living J Comput Mol Sci"},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0395","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0400","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF chimerax: meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0405","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF chimerax: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2025.148124_bb0410","doi-asserted-by":"crossref","first-page":"W420","DOI":"10.1093\/nar\/gkac373","article-title":"IBS 2.0: an upgraded illustrator for the visualization of biological sequences","volume":"50","author":"Xie","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025086817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025086817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:41:31Z","timestamp":1781743291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025086817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":82,"alternative-id":["S0141813025086817"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148124","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural perspective on the design of selective DYRK1B inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148124"}}